Church & Dwight Co., Inc.

The filings show a company growing volume while spending more to support its brands and integrate acquisitions. Segment results for the first quarter of 2026 show Consumer Domestic net sales of $1,117.7 million, down 1.1%, with income from operations of $240.2 million, down $4.6 million. Consumer International net sales rose 4.6% to $273.9 million, with income of $39.9 million. Specialty Products (SPD) net sales were $77.7 million, with income of $10.9 million, down $1.9 million. Management points to growth in brands such as THERABREATH, HERO, ARM & HAMMER Cat Litter and OXICLEAN, while WATERPIK Oral Care declined. On the balance sheet, the company reported $503.4 million in cash and cash equivalents as of March 31, 2026, and about $1,993.0 million available through its revolving credit facility and commercial paper program. The $2,000.0 million unsecured revolver matures July 17, 2030. Interest expense was $24.0 million, up $0.7 million, while interest income fell $6.8 million to $2.5 million on lower average cash balances. No shares were repurchased under the share programs in the quarter, apart from shares withheld for tax obligations, and $228.9 million remained under the 2021 program. Over a longer span, operating income was $1.08 billion for 2025, compared with $807.1 million in 2024 and $1.06 billion in 2023. No forensic scores are on file for this company, so this synthesis does not assess the Beneish M-Score, Piotroski F-Score, Altman Z-Score or Fog Index. Readers may want to look at the full Item 1A risk factors in the Form 10-K, and at the segment income discussion, to see whether the cost pressures from tariffs and SG&A investment persist into later quarters.

Catalyst.Volume is carrying the top line while portfolio pruning offsets it. In the first quarter of 2026, net sales were $1,469.3 million, up 0.2% from $1,467.1 million. Product volumes rose 5.3%, and the Touchland acquisition, completed in July 2025, added 2.2%. Exits of product lines reduced sales by 8.1%, including the vitamin business divested in the fourth quarter of 2025 and the Flawless, Spinbrush and Waterpik showerhead businesses. Gross margin rose 140 basis points to 46.4%, which management attributed mainly to productivity programs worth 150 basis points. Full-year 2025 revenue was $6.2 billion, compared with $6.11 billion in 2024.

Hidden risk.The 0.2% sales increase understates how much the portfolio is being reshaped. Pricing and product mix was negative at 0.3%, and management cites unfavorable price/mix in Consumer Domestic and Consumer International. Higher manufacturing costs reduced gross margin by 180 basis points, including labor, commodity inflation, transportation and higher tariffs. SG&A rose 10.2% to $251.0 million, or 17.1% of net sales versus 15.5% a year earlier. As a result, operating income fell 1.5% to $291.0 million and operating margin slipped to 19.8% from 20.2%, even though gross margin improved. The risk factor excerpt provided only refers readers to the Form 10-K, so the full risk text is not in this data.